ALK-POSITIVE

Clinical trials for ALK-POSITIVE explained in plain language.

Never miss a new study

Get alerted when new ALK-POSITIVE trials appear

Sign up with your email to follow new studies for ALK-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2

New study aims to tame cholesterol side effect of lung cancer drug

Disease control Not yet recruiting

This study looks at the best way to manage high cholesterol caused by the targeted therapy lorlatinib in people with advanced ALK-positive non-small cell lung cancer. Some participants receive standard cholesterol-lowering drugs, while others get a more intensive combination. The…

Matched conditions: ALK-POSITIVE

Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC

ALK-POSITIVE

Get alerted when new ALK-POSITIVE trials appear

New study aims to tame cholesterol side effect of lung cancer drug